- People
- Offices
- Practices
back- Practices
- Transactional
- back
- Transactional
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Employee Benefits and Executive Compensation
- Finance
- Financial Restructuring
- Intellectual Property Counseling
- Mergers & Acquisitions
- Middle East and Islamic Finance and Investment
- Private Equity
- Projects and Infrastructure
- Real Estate
- Tax
- Government & Regulatory
- Litigation
- back
- Litigation
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Construction and Engineering Disputes
- Contracts and Business Torts
- Data, Privacy & Security
- E-Discovery
- Environmental
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Mass Tort and Toxic Tort
- Product Liability
- Professional Liability
- Securities Enforcement and Regulation
- Securities and Shareholder Litigation
- Special Matters and Investigations
- Tax Controversy
- Careers
- News & Insights
- About
- Languages
People
Bobby Woo focuses on product liability defense, including medical devices, pharmaceuticals and other consumer products. As a partner in our Mass Tort and Toxic Tort practice, Bobby represents healthcare-related firms and consumer product companies in a variety of matters.
With more than 23 years of experience in state and federal courts, Bobby represents pharmaceutical and medical device manufacturers in product liability litigation, particularly in mass tort settings.
Bobby was part of the team that served as national coordinating co-counsel for Purdue Pharma in product liability litigation involving the pain medication OxyContin®. In that litigation, Purdue obtained more than 400 dismissals, including over 30 orders granting summary judgment, and defeated 15 putative class actions.
More recently, Bobby has represented GlaxoSmithKline as part of the company's national coordinating counsel in product liability litigation involving the antidepressant Paxil®. Bobby served as lead counsel for defendants in case conferences and special master hearings for the Paxil® pregnancy cases in the Pennsylvania Mass Tort Program, which at the time had been designated as the number one “Judicial Hellhole” in the country for two years running by the American Tort Reform Foundation.
Bobby has been recognized by Legal 500 (2010–2011) for Product Liability/Mass Tort defense in pharmaceutical and medical device cases. He has also received recognition in Georgia Super Lawyers magazine (2005–2007, 2009).
Bobby is active in the National Asian Pacific American Bar Association, which awarded him the Daniel K. Inouye Trailblazer Award, NAPABA’s highest honor, in 2002. Bobby also received the inaugural Judge Alvin T. Wong Pioneer Award for his leadership in the Georgia APA legal community. Within our firm, Bobby has served on the Diversity and Hiring Committees and is currently the Atlanta office Hiring Partner.
Bobby has appeared on panels addressing issues such as the attorney-client privilege, expert witnesses and scientific evidence, diversity, professionalism, and civil procedure; for the last seven years, has been responsible for training the firm’s new attorneys on efficient legal research techniques.
Credentials
B.A., Harvard University, magna cum laude
J.D., Harvard University, cum laude
U.S. Court of Appeals for the Third Circuit
U.S. Court of Appeals for the Sixth Circuit
U.S. Court of Appeals for the Eleventh Circuit
U.S. District Court for the Eastern District of Wisconsin
U.S. District Court for the Northern District of Georgia
Georgia
Law Clerk, Hon. Stanley F. Birch Jr., U.S. Court of Appeals for the Eleventh Circuit
National Asian Pacific American Bar Association, Georgia Chapter (1994- )
Georgia Asylum and Immigration Network (Board Member 2006)
State Bar of Georgia Access to Justice Committee (f/k/a Pro Bono Committee) (1999)
State Bar of Georgia Diversity Program (1999)
State Bar of Georgia, Women and Minorities in the Profession Committee (1999)
State Bar of Georgia (1995–Present)
Supreme Court of Georgia's Commission on Fairness and Access in the Courts (2006–Present)
International Association of Defense Counsel (2008–Present)
National Asian Pacific American Bar Association, Georgia Chapter (1994–Present)
Leadership DeKalb (1996)
Outstanding Atlanta (1998)
Leadership Atlanta (2000)
News
Cases & Deals
February 23, 2017
King & Spalding Advises Carter’s in $140 Million Acquisition
Matters
Defended a major pharmaceutical company facing more than 600 cases alleging that maternal use of a prescription medication caused congenital malformations; lead attorney in case management and special master hearings in the Mass Tort Program (MTP) in Philadelphia, where the bulk of these cases are pending.
Drafted amicus brief to the Supreme Court of Georgia on behalf of the four largest Asian-Pacific American civil rights groups in the country regarding the use of court interpreters for criminal defendants during plea bargain negotiations; resulted in conviction being vacated and case remanded for re-trial.
Defended a major pharmaceutical company involved in more than 1,300 individual and class action suits, filed in more than 32 states, alleging failure to warn and overly-aggressive marketing of a prescription medication; part of a team that defeated class certification in numerous courts and obtained 410 dismissals, including 27 orders granting summary judgment.
See more
Close
Matters
Defended a major pharmaceutical company facing more than 600 cases alleging that maternal use of a prescription medication caused congenital malformations; lead attorney in case management and special master hearings in the Mass Tort Program (MTP) in Philadelphia, where the bulk of these cases are pending.
Drafted amicus brief to the Supreme Court of Georgia on behalf of the four largest Asian-Pacific American civil rights groups in the country regarding the use of court interpreters for criminal defendants during plea bargain negotiations; resulted in conviction being vacated and case remanded for re-trial.
Defended a major pharmaceutical company involved in more than 1,300 individual and class action suits, filed in more than 32 states, alleging failure to warn and overly-aggressive marketing of a prescription medication; part of a team that defeated class certification in numerous courts and obtained 410 dismissals, including 27 orders granting summary judgment.
Led a team of attorneys on two asylum cases on behalf of a pair of Ivory Coast citizens who had suffered persecution on account of their political activities, pursuing the matter through trial (merits hearing) and an appeal before the Board of Immigration Appeals.
Defended a major manufacturer of consumer goods and medical products in dozens of product liability cases involving silicone breast implants.
Authored chapter on "Expert Testimony, Rule 702, and Daubert" in Drug and Device Product Liability Litigation Strategy (2d. ed. forthcoming).
Co-authored chapter on "Attorney-Client Privilege" in the treatise Regulation of Pharmaceutical Manufacturers (2012).
Authored “Managing the Real Estate Investment Trust: An Alternative to the Independent Contractor Requirement,” 107 Harvard Law Review 1117 (1994), reprinted in The Monthly Digest of Tax Articles (February 1995).
Bobby has appeared on panels addressing issues such as the attorney-client privilege, expert witnesses and scientific evidence, diversity, professionalism, and civil procedure; for the last seven years, has been responsible for training the firm’s new attorneys on efficient legal research techniques.
News
Cases & Deals
February 23, 2017
King & Spalding Advises Carter’s in $140 Million Acquisition
Matters
Defended a major pharmaceutical company facing more than 600 cases alleging that maternal use of a prescription medication caused congenital malformations; lead attorney in case management and special master hearings in the Mass Tort Program (MTP) in Philadelphia, where the bulk of these cases are pending.
Drafted amicus brief to the Supreme Court of Georgia on behalf of the four largest Asian-Pacific American civil rights groups in the country regarding the use of court interpreters for criminal defendants during plea bargain negotiations; resulted in conviction being vacated and case remanded for re-trial.
Defended a major pharmaceutical company involved in more than 1,300 individual and class action suits, filed in more than 32 states, alleging failure to warn and overly-aggressive marketing of a prescription medication; part of a team that defeated class certification in numerous courts and obtained 410 dismissals, including 27 orders granting summary judgment.
See more
Close
Matters
Defended a major pharmaceutical company facing more than 600 cases alleging that maternal use of a prescription medication caused congenital malformations; lead attorney in case management and special master hearings in the Mass Tort Program (MTP) in Philadelphia, where the bulk of these cases are pending.
Drafted amicus brief to the Supreme Court of Georgia on behalf of the four largest Asian-Pacific American civil rights groups in the country regarding the use of court interpreters for criminal defendants during plea bargain negotiations; resulted in conviction being vacated and case remanded for re-trial.
Defended a major pharmaceutical company involved in more than 1,300 individual and class action suits, filed in more than 32 states, alleging failure to warn and overly-aggressive marketing of a prescription medication; part of a team that defeated class certification in numerous courts and obtained 410 dismissals, including 27 orders granting summary judgment.
Led a team of attorneys on two asylum cases on behalf of a pair of Ivory Coast citizens who had suffered persecution on account of their political activities, pursuing the matter through trial (merits hearing) and an appeal before the Board of Immigration Appeals.
Defended a major manufacturer of consumer goods and medical products in dozens of product liability cases involving silicone breast implants.
Authored chapter on "Expert Testimony, Rule 702, and Daubert" in Drug and Device Product Liability Litigation Strategy (2d. ed. forthcoming).
Co-authored chapter on "Attorney-Client Privilege" in the treatise Regulation of Pharmaceutical Manufacturers (2012).
Authored “Managing the Real Estate Investment Trust: An Alternative to the Independent Contractor Requirement,” 107 Harvard Law Review 1117 (1994), reprinted in The Monthly Digest of Tax Articles (February 1995).
Bobby has appeared on panels addressing issues such as the attorney-client privilege, expert witnesses and scientific evidence, diversity, professionalism, and civil procedure; for the last seven years, has been responsible for training the firm’s new attorneys on efficient legal research techniques.
News
Cases & Deals
February 23, 2017
King & Spalding Advises Carter’s in $140 Million Acquisition
Credentials
B.A., Harvard University, magna cum laude
J.D., Harvard University, cum laude
U.S. Court of Appeals for the Third Circuit
U.S. Court of Appeals for the Sixth Circuit
U.S. Court of Appeals for the Eleventh Circuit
U.S. District Court for the Eastern District of Wisconsin
U.S. District Court for the Northern District of Georgia
Georgia
Law Clerk, Hon. Stanley F. Birch Jr., U.S. Court of Appeals for the Eleventh Circuit
National Asian Pacific American Bar Association, Georgia Chapter (1994- )
Georgia Asylum and Immigration Network (Board Member 2006)
State Bar of Georgia Access to Justice Committee (f/k/a Pro Bono Committee) (1999)
State Bar of Georgia Diversity Program (1999)
State Bar of Georgia, Women and Minorities in the Profession Committee (1999)
State Bar of Georgia (1995–Present)
Supreme Court of Georgia's Commission on Fairness and Access in the Courts (2006–Present)
International Association of Defense Counsel (2008–Present)
National Asian Pacific American Bar Association, Georgia Chapter (1994–Present)
Leadership DeKalb (1996)
Outstanding Atlanta (1998)
Leadership Atlanta (2000)